Your browser doesn't support javascript.
Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?
Sanchis-Gomar, Fabian; Perez-Quilis, Carme; Lavie, Carl J.
  • Sanchis-Gomar F; Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.
  • Perez-Quilis C; Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Lavie CJ; Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.
Eur Heart J ; 41(32): 3092-3093, 2020 07 01.
Article in English | MEDLINE | ID: covidwho-657493
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Atrial Fibrillation / Cardiovascular Diseases / Coronavirus Infections / Pandemics Type of study: Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur Heart J Year: 2020 Document Type: Article Affiliation country: Eurheartj

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Atrial Fibrillation / Cardiovascular Diseases / Coronavirus Infections / Pandemics Type of study: Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur Heart J Year: 2020 Document Type: Article Affiliation country: Eurheartj